Sneha M Sundaram1, Lorinda Chung2,3. 1. Department of Internal Medicine, California Pacific Medical Center, San Francisco, CA, USA. 2. Division of Immunology and Rheumatology, Stanford University, 1000 Welch Road, Suite 201, Palo Alto, CA, 94304, USA. shauwei@stanford.edu. 3. VA Palo Alto Health Care System, Palo Alto, CA, 94304, USA. shauwei@stanford.edu.
Abstract
PURPOSE OF REVIEW: This review will summarize the most current literature on the clinical impact, epidemiology, risk factors, screening recommendations, predictors of outcomes, and treatment options in patients with pulmonary arterial hypertension (PAH) associated with systemic sclerosis (SSc). RECENT FINDINGS: PAH continues to be a major cause of morbidity and mortality in SSc. Many risk factors and predictors of outcomes have been identified in patients with SSc including clinical, hemodynamic, and laboratory parameters. Screening for PAH in SSc patients is important and screening algorithms have been developed. Despite many available treatment options for PAH, prognosis remains poor. Awareness of risk factors, early detection, and up-front combination treatment are important considerations in SSc-PAH and may lead to improved outcomes. Further research to develop better biomarkers and therapies is needed to continue to improve survival and outcomes in patients with SSc-PAH.
PURPOSE OF REVIEW: This review will summarize the most current literature on the clinical impact, epidemiology, risk factors, screening recommendations, predictors of outcomes, and treatment options in patients with pulmonary arterial hypertension (PAH) associated with systemic sclerosis (SSc). RECENT FINDINGS: PAH continues to be a major cause of morbidity and mortality in SSc. Many risk factors and predictors of outcomes have been identified in patients with SSc including clinical, hemodynamic, and laboratory parameters. Screening for PAH in SSc patients is important and screening algorithms have been developed. Despite many available treatment options for PAH, prognosis remains poor. Awareness of risk factors, early detection, and up-front combination treatment are important considerations in SSc-PAH and may lead to improved outcomes. Further research to develop better biomarkers and therapies is needed to continue to improve survival and outcomes in patients with SSc-PAH.
Authors: Matthew R Lammi; Stephen C Mathai; Lesley Ann Saketkoo; Robyn T Domsic; Christine Bojanowski; Daniel E Furst; Virginia D Steen Journal: Arthritis Rheumatol Date: 2016-03 Impact factor: 10.995
Authors: Irfan Y Khan; Lianne G Singer; Marc de Perrot; John T Granton; Shaf Keshavjee; Cathy Chau; Amie Kron; Sindhu R Johnson Journal: Respir Med Date: 2013-09-26 Impact factor: 3.415
Authors: Lorinda Chung; Robert M Fairchild; Daniel E Furst; Shufeng Li; Firas Alkassab; Marcy B Bolster; Mary Ellen Csuka; Chris T Derk; Robyn T Domsic; Aryeh Fischer; Tracy M Frech; Mardi Gomberg-Maitland; Jessica K Gordon; Monique Hinchcliff; Vivien Hsu; Laura K Hummers; Dinesh Khanna; Thomas A Jr Medsger; Jerry A Molitor; Ivana R Preston; Elena Schiopu; Lee Shapiro; Faye Hant; Richard Silver; Robert Simms; John Varga; Virginia D Steen; Roham T Zamanian Journal: Clin Exp Rheumatol Date: 2016-11-10 Impact factor: 4.473
Authors: David B Badesch; Nicholas S Hill; Gary Burgess; Lewis J Rubin; Robyn J Barst; Nazzareno Galiè; Gerald Simonneau Journal: J Rheumatol Date: 2007-11-01 Impact factor: 4.666
Authors: Lionel Schachna; Fredrick M Wigley; Betty Chang; Barbara White; Robert A Wise; Allan C Gelber Journal: Chest Date: 2003-12 Impact factor: 9.410
Authors: Nazzareno Galiè; Marius M Hoeper; Marc Humbert; Adam Torbicki; Jean-Luc Vachiery; Joan Albert Barbera; Maurice Beghetti; Paul Corris; Sean Gaine; J Simon Gibbs; Miguel Angel Gomez-Sanchez; Guillaume Jondeau; Walter Klepetko; Christian Opitz; Andrew Peacock; Lewis Rubin; Michael Zellweger; Gerald Simonneau Journal: Eur Heart J Date: 2009-08-27 Impact factor: 29.983
Authors: Karen M Olsson; Marion Delcroix; H Ardeschir Ghofrani; Henning Tiede; Doerte Huscher; Rudolf Speich; Ekkehard Grünig; Gerd Staehler; Stephan Rosenkranz; Michael Halank; Matthias Held; Tobias J Lange; Juergen Behr; Hans Klose; Martin Claussen; Ralf Ewert; Christian F Opitz; C Dario Vizza; Laura Scelsi; Anton Vonk-Noordegraaf; Harald Kaemmerer; J Simon R Gibbs; Gerry Coghlan; Joanna Pepke-Zaba; Uwe Schulz; Matthias Gorenflo; David Pittrow; Marius M Hoeper Journal: Circulation Date: 2013-09-30 Impact factor: 29.690
Authors: Catherine H Miele; Kristin Schwab; Rajeev Saggar; Erin Duffy; David Elashoff; Chi-Hong Tseng; Sam Weigt; Deepshikha Charan; Fereidoun Abtin; Jimmy Johannes; Ariss Derhovanessian; Jeffrey Conklin; Kevin Ghassemi; Dinesh Khanna; Osama Siddiqui; Abbas Ardehali; Curtis Hunter; Murray Kwon; Reshma Biniwale; Michelle Lo; Elizabeth Volkmann; David Torres Barba; John A Belperio; David Sayah; Thomas Mahrer; Daniel E Furst; Suzanne Kafaja; Philip Clements; Michael Shino; Aric Gregson; Bernard Kubak; Joseph P Lynch; David Ross; Rajan Saggar Journal: Ann Am Thorac Soc Date: 2016-06
Authors: Christopher R Pasarikovski; John T Granton; Adrienne M Roos; Saghar Sadeghi; Amie T Kron; John Thenganatt; Jakov Moric; Cathy Chau; Sindhu R Johnson Journal: Arthritis Res Ther Date: 2016-01-27 Impact factor: 5.156